{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:24:05Z","timestamp":1787905445058,"version":"build-2784847793"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["rep.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:title>\u2003<\/jats:title>\n                  <jats:sec>\n                    <jats:title>In brief<\/jats:title>\n                    <jats:p>Preterm birth is the leading cause of perinatal morbidity and mortality; however, current therapies offer limited efficacy to delay birth and improve neonatal outcomes. This review explores the potential of repurposing drugs with known safety profiles to quench uterine contractions and inflammation, identifying promising agents for clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Preterm birth is the leading cause of neonatal morbidity and mortality globally. Despite extensive research into the underlying pathophysiology, rates of preterm birth have not significantly reduced. Currently, preterm labour management is based on optimising neonatal outcomes. Treatment involves administering drugs (tocolytics) to suppress uterine contractions to allow sufficient time for transfer to an appropriate facility and administration of antenatal corticosteroids for fetal lung maturation. Current tocolytics are limited as they are associated with adverse maternal and fetal effects and only delay delivery for a short period. There has been a serious lack of therapeutic development for preterm birth, and new approaches to protect against or delay preterm birth are urgently needed. Repurposing drugs for the prevention of preterm birth presents as a promising approach by reducing the time and costs associated with pharmaceutical drug development. In this review, we explore the evidence for the potential of therapies, specifically proton pump inhibitors, tumour necrosis factor inhibitors, prostaglandin receptor antagonists, aspirin, and statins, to be repurposed as preventatives and\/or treatments for preterm birth. Importantly, many of these innovative approaches being explored have good safety profiles in pregnancy. We also review how delivery of these drugs can be enhanced, either through targeted delivery systems or via combination therapy approaches. We aim to present innovative strategies capable of targeting multiple aspects of the complex pathophysiology that underlie preterm birth. There is an urgent unmet need for preterm birth therapeutic development, and these strategies hold great promise for improving neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/rep-22-0226","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T09:37:22Z","timestamp":1666949842000},"page":"R9-R23","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-11","source":"Crossref","is-referenced-by-count":15,"title":["Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth"],"prefix":"10.1093","volume":"165","author":[{"given":"Bridget M","family":"Arman","sequence":"first","affiliation":[{"name":"Therapeutics Discovery and Vascular Function Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology , University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K","family":"Binder","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology , University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-0096","authenticated-orcid":false,"given":"Natasha","family":"de Alwis","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology , University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u2019uhevaha J","family":"Kaitu\u2019u-Lino","sequence":"additional","affiliation":[{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology , University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-2250","authenticated-orcid":false,"given":"Natalie J","family":"Hannan","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Department of Obstetrics and Gynaecology , University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"2026021212262259200_bib1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI927","article-title":"Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy","volume":"101","author":"Acevedo","year":"1998","journal-title":"Journal of Clinical Investigation"},{"key":"2026021212262259200_bib2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG"},{"key":"2026021212262259200_bib3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijgo.12793","article-title":"Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor","volume":"145","author":"Ali","year":"2019","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"2026021212262259200_bib4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3329\/bjog.v23i2.4962","article-title":"A prospective randomised trial of nifedipine versus placebo in preterm labour","volume":"23","author":"Ara","year":"2008","journal-title":"Bangladesh Journal of Obstetrics and Gynaecology"},{"key":"2026021212262259200_bib5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nature Reviews. Drug Discovery"},{"key":"2026021212262259200_bib6","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"2026021212262259200_bib7","doi-asserted-by":"publisher","DOI":"10.26420\/austiniobstetgynecol.2021.1189","article-title":"Role of esomeprazole in early preeclampsia: a randomized controlled trial","volume":"8","author":"Atwa","year":"2021","journal-title":"Austin Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib8","doi-asserted-by":"publisher","first-page":"224.e1","DOI":"10.1016\/j.ajog.2012.06.020","article-title":"Can statins reduce the inflammatory response associated with preterm birth in an animal model?","volume":"207","author":"Basraon","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib9","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1096\/fj.201801104R","article-title":"Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models","volume":"33","author":"Boyle","year":"2019","journal-title":"FASEB Journal"},{"key":"2026021212262259200_bib10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/pds.4930","article-title":"Anti-TNF treatment during pregnancy and birth outcomes: a population-based study from Denmark, Finland, and Sweden","volume":"29","author":"Broms","year":"2020","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"2026021212262259200_bib11","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"16","author":"Brownfoot","year":"2016","journal-title":"BMC Pregnancy and Childbirth"},{"key":"2026021212262259200_bib12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1476-5381.2012.02239.x","article-title":"Role of TNF-alpha in the mechanisms responsible for preterm delivery induced by Stx2 in rats","volume":"168","author":"Burdet","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"2026021212262259200_bib13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapediatrics.2022.1622","article-title":"Global, regional, and national incidence and mortality of neonatal preterm birth, 1990\u20132019","volume":"176","author":"Cao","year":"2022","journal-title":"JAMA Pediatrics"},{"key":"2026021212262259200_bib14","doi-asserted-by":"publisher","first-page":"388.e1","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132912","article-title":"Landscape of preterm birth therapeutics and a path forward","volume":"10","author":"Coler","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"2026021212262259200_bib16","doi-asserted-by":"publisher","first-page":"720.e721","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib17","doi-asserted-by":"publisher","first-page":"666.e661","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.gim.0000187223.69947.db","article-title":"Genetic variation associated with preterm birth: a HuGE review","volume":"7","author":"Crider","year":"2005","journal-title":"Genetics in Medicine"},{"key":"2026021212262259200_bib19","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1016\/S0021-9258(1842276-4","article-title":"Isolation and characterization of a cDNA encoding the putative distal colon H+,K(+)-ATPase. Similarity of deduced amino acid sequence to gastric H+,K(+)-ATPase and Na+,K(+)-ATPase and mRNA expression in distal colon, kidney, and uterus","volume":"267","author":"Crowson","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"2026021212262259200_bib20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.preghy.2020.03.004","article-title":"Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction","volume":"20","author":"de Alwis","year":"2020","journal-title":"Pregnancy Hypertension"},{"key":"2026021212262259200_bib21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/14767050802702349","article-title":"The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow","volume":"22","author":"de Heus","year":"2009","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"2026021212262259200_bib22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tjog.2015.07.005","article-title":"Progesterone and nifedipine for maintenance tocolysis after arrested preterm labor: a systematic review and meta-analysis of randomized controlled trial","volume":"55","author":"Ding","year":"2016","journal-title":"Taiwanese Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1471-0528.2002.01518.x","article-title":"In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents","volume":"109","author":"Doret","year":"2002","journal-title":"BJOG"},{"key":"2026021212262259200_bib24","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJM200404083501524","article-title":"Central nervous system and limb anomalies in case reports of first-trimester statin exposure","volume":"350","author":"Edison","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"2026021212262259200_bib25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/107155769700400104","article-title":"Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice","volume":"4","author":"Fidel","year":"1997","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"2026021212262259200_bib26","doi-asserted-by":"publisher","first-page":"CD004452","DOI":"10.1002\/14651858.CD004452.pub3","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","volume":"6","author":"Flenady","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib27","doi-asserted-by":"publisher","first-page":"CD002255","DOI":"10.1002\/14651858.CD002255.pub2","article-title":"Calcium channel blockers for inhibiting preterm labour and birth","volume":"6","author":"Flenady","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/0002-9378(8490677-x","article-title":"Oxytocin receptors in the human uterus during pregnancy and parturition","volume":"150","author":"Fuchs","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib29","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"2026021212262259200_bib30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.siny.2017.11.007","article-title":"Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: a review","volume":"23","author":"Glover","year":"2018","journal-title":"Seminars in Fetal and Neonatal Medicine"},{"key":"2026021212262259200_bib31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(0860074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"2026021212262259200_bib32","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/REP-22-0046","article-title":"The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis","volume":"164","author":"Gomez-Lopez","year":"2022","journal-title":"Reproduction"},{"key":"2026021212262259200_bib33","doi-asserted-by":"publisher","first-page":"e146089-146081","DOI":"10.1172\/jci.insight.146089","article-title":"Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injury","volume":"6","author":"Gomez-Lopez","year":"2021","journal-title":"JCI Insight"},{"key":"2026021212262259200_bib34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/molehr\/gau019","article-title":"Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition","volume":"20","author":"Gonzalez","year":"2014","journal-title":"Molecular Human Reproduction"},{"issue":"Supplement 2","key":"2026021212262259200_bib35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14767050902860690","article-title":"The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth","volume":"22","author":"Gotsch","year":"2009","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"2026021212262259200_bib36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/uog.19186","article-title":"Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium","volume":"52","author":"Groom","year":"2018","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"2026021212262259200_bib37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00441-022-03587-z","article-title":"Esomeprazole inhibits hypoxia\/endothelial dysfunction-induced autophagy in preeclampsia","volume":"388","author":"Gu","year":"2022","journal-title":"Cell and Tissue Research"},{"key":"2026021212262259200_bib38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"2026021212262259200_bib39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0165-6147(9701147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA Reductase Inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends in Pharmacological Sciences"},{"key":"2026021212262259200_bib40","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:104993","article-title":"Births: provisional data for 2020","author":"Hamilton","year":"2021","journal-title":"Vital Statistics Rapid Release"},{"key":"2026021212262259200_bib41","doi-asserted-by":"publisher","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/L14-5020-5","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia","volume":"161","author":"Henderson","year":"2014","journal-title":"Annals of Internal Medicine"},{"key":"2026021212262259200_bib43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(1932973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (Aspirin): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"2026021212262259200_bib44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jri.2007.11.003","article-title":"Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model","volume":"78","author":"Holmgren","year":"2008","journal-title":"Journal of Reproductive Immunology"},{"key":"2026021212262259200_bib45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1210\/en.2010-1105","article-title":"The molecular mechanisms of cervical ripening differ between term and preterm birth","volume":"152","author":"Holt","year":"2011","journal-title":"Endocrinology"},{"key":"2026021212262259200_bib46","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03951-x","article-title":"The effectiveness of nifedipine\/indomethacin combination therapy and nifedipine monotherapy for postponing preterm birth (25\u201334 weeks of gestation) in Sudanese women: a randomized clinical trial study protocol","volume":"21","author":"Ibrahim","year":"2021","journal-title":"BMC Pregnancy and Childbirth"},{"key":"2026021212262259200_bib47","doi-asserted-by":"publisher","first-page":"C1080","DOI":"10.1152\/ajpcell.1993.265.4.C1080","article-title":"A putative H(+)-K(+)-ATPase is selectively expressed in surface epithelial cells of rat distal colon","volume":"265","author":"Jaisser","year":"1993","journal-title":"American Journal of Physiology"},{"key":"2026021212262259200_bib48","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1080\/14767058.2019.1570117","article-title":"A comparative study on the efficacy of nifedipine and indomethacin for prevention of preterm birth as monotherapy and combination therapy: a randomized clinical trial","volume":"33","author":"Kashanian","year":"2020","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"2026021212262259200_bib49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/s0950-3552(0580189-0","article-title":"Therapeutic uses of prostaglandins","volume":"6","author":"Keirse","year":"1992","journal-title":"Bailliere's Clinical Obstetrics and Gynaecology"},{"key":"2026021212262259200_bib50","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2026021212262259200_bib51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003892","article-title":"Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial","volume":"19","author":"Landman","year":"2022","journal-title":"PLOS Medicine"},{"key":"2026021212262259200_bib52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/REP-09-0160","article-title":"RHO protein regulation of contraction in the human uterus","volume":"138","author":"Lartey","year":"2009","journal-title":"Reproduction"},{"key":"2026021212262259200_bib53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133761","article-title":"Computational discovery of therapeutic candidates for preventing preterm birth","volume":"5","author":"Le","year":"2020","journal-title":"JCI Insight"},{"key":"2026021212262259200_bib54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jgyn.2010.04.004","article-title":"Goffinet F & Groupe Evaprima","volume":"39","author":"Le Ray","year":"2010","journal-title":"Journal de Gyn\u00e9cologie, Obst\u00e9trique et Biologie de la Reproduction"},{"key":"2026021212262259200_bib55","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1542\/peds.111.1.e77","article-title":"Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation","volume":"111","author":"Leonhardt","year":"2003","journal-title":"Pediatrics"},{"issue":"Supplement 20","key":"2026021212262259200_bib56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.00023.x","article-title":"Mechanisms of labour--biochemical aspects","volume":"110","author":"Lopez Bernal","year":"2003","journal-title":"BJOG"},{"key":"2026021212262259200_bib57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/1099800409344620","article-title":"Integrated review of cytokines in maternal, cord, and newborn blood: Part I\u2014Associations with preterm birth","volume":"11","author":"Lyon","year":"2010","journal-title":"Biological Research for Nursing"},{"key":"2026021212262259200_bib58","doi-asserted-by":"publisher","first-page":"CD007062","DOI":"10.1002\/14651858.CD007062.pub3","article-title":"Tocolytics for preterm premature rupture of membranes","volume":"2","author":"Mackeen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib60","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1080\/03007995.2021.1944076","article-title":"Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban","volume":"37","author":"Marchand","year":"2021","journal-title":"Current Medical Research and Opinion"},{"key":"2026021212262259200_bib61","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1210\/jcem-71-5-1243","article-title":"Regulation of intracellular free calcium in human myometrial cells by prostaglandin F2 alpha: comparison with oxytocin","volume":"71","author":"Molnar","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2026021212262259200_bib62","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1530\/REP-16-0453","article-title":"Sterile inflammation and pregnancy complications: a review","volume":"152","author":"Nadeau-Vallee","year":"2016","journal-title":"Reproduction"},{"key":"2026021212262259200_bib63","doi-asserted-by":"publisher","first-page":"CD004071","DOI":"10.1002\/14651858.CD004071.pub3","article-title":"Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour","volume":"10","author":"Naik Gaunekar","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib64","doi-asserted-by":"publisher","first-page":"CD004352","DOI":"10.1002\/14651858.CD004352.pub3","article-title":"Betamimetics for inhibiting preterm labour","volume":"2","author":"Neilson","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib65","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/HYPERTENSIONAHA.122.19070","article-title":"Omeprazole administration in preterm preeclampsia: a randomized controlled trial to study its effect on sFlt-1 (soluble Fms-like tyrosine Kinase-1), PlGF (placental growth factor), and ET-1 (endothelin-1)","volume":"79","author":"Neuman","year":"2022","journal-title":"Hypertension"},{"key":"2026021212262259200_bib66","article-title":"ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopiprant (OBE022) for the treatment of Spontaneous preterm labor at the RCOG Virtual World Congress 2021","author":"ObsEva","year":"2021"},{"key":"2026021212262259200_bib67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1517\/14728210802568764","article-title":"Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy","volume":"13","author":"Olson","year":"2008","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"2026021212262259200_bib68","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine Kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"2026021212262259200_bib69","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects","volume":"363","author":"Pasternak","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"2026021212262259200_bib70","doi-asserted-by":"publisher","first-page":"283.e1","DOI":"10.1016\/j.ajog.2016.08.027","article-title":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","volume":"216","author":"Paul","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000085957","article-title":"Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin","volume":"74","author":"Perez-Guerrero","year":"2005","journal-title":"Pharmacology"},{"key":"2026021212262259200_bib72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/jpet.118.247668","article-title":"OBE022, an oral and selective prostaglandin F2alpha receptor antagonist as an effective and safe modality for the treatment of preterm labor","volume":"366","author":"Pohl","year":"2018","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2026021212262259200_bib73","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/bcp.13622","article-title":"Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2alpha receptor antagonist tocolytic: a first-in-human trial in healthy postmenopausal women","volume":"84","author":"Pohl","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2026021212262259200_bib74","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/bcp.13925","article-title":"Coadministration of the prostaglandin F2alpha receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone","volume":"85","author":"Pohl","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2026021212262259200_bib75","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/humupd\/dmaa049","article-title":"Nanoparticles in pregnancy: the next frontier in reproductive therapeutics","volume":"27","author":"Pritchard","year":"2021","journal-title":"Human Reproduction Update"},{"key":"2026021212262259200_bib76","doi-asserted-by":"publisher","first-page":"508.e1","DOI":"10.1016\/j.ajog.2015.02.006","article-title":"Liposomes: a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model","volume":"212","author":"Refuerzo","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib77","doi-asserted-by":"publisher","first-page":"34710","DOI":"10.1038\/srep34710","article-title":"Uterus-targeted liposomes for preterm labor management: studies in pregnant mice","volume":"6","author":"Refuerzo","year":"2016","journal-title":"Scientific Reports"},{"key":"2026021212262259200_bib78","doi-asserted-by":"publisher","first-page":"CD001992","DOI":"10.1002\/14651858.CD001992.pub3","article-title":"Cyclo-oxygenase (COX) inhibitors for treating preterm labour","volume":"6","author":"Reinebrant","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib79","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3565(25)12412-9","article-title":"H+-K+ ATPase inhibitors cause relaxation of guinea pig and human airway smooth muscle in vitro","volume":"276","author":"Rhoden","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2026021212262259200_bib80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"2026021212262259200_bib81","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1121","article-title":"Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury","volume":"9","author":"Robertson","year":"2020","journal-title":"Clinical and Translational Immunology"},{"key":"2026021212262259200_bib82","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science"},{"issue":"Supplement 3","key":"2026021212262259200_bib83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"issue":"Supplement 2","key":"2026021212262259200_bib84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-3016.2001.00007.x","article-title":"The role of infection in preterm labour and delivery","volume":"15","author":"Romero","year":"2001","journal-title":"Paediatric and Perinatal Epidemiology"},{"key":"2026021212262259200_bib85","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ajog.2006.06.072","article-title":"Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model","volume":"195","author":"Sadowsky","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib86","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low soluble Fms-like tyrosine Kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"2026021212262259200_bib87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12868-019-0529-1","article-title":"TNF-alpha antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats","volume":"20","author":"Shin","year":"2019","journal-title":"BMC Neuroscience"},{"key":"2026021212262259200_bib88","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/s0002-9378(9770545-3","article-title":"Bacterial lipopolysaccharide-mediated murine fetal death: the role of interleukin-1","volume":"176","author":"Silver","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib89","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","article-title":"Role of complement component C1q in the onset of preeclampsia in mice","volume":"58","author":"Singh","year":"2011","journal-title":"Hypertension"},{"key":"2026021212262259200_bib90","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/JOE-16-0157","article-title":"Myometrial cytokines and their role in the onset of labour","volume":"231","author":"Sivarajasingam","year":"2016","journal-title":"Journal of Endocrinology"},{"key":"2026021212262259200_bib91","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/molehr\/5.9.880","article-title":"Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy","volume":"5","author":"Slater","year":"1999","journal-title":"Molecular Human Reproduction"},{"key":"2026021212262259200_bib92","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1095\/biolreprod46.5.772","article-title":"Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells","volume":"46","author":"So","year":"1992","journal-title":"Biology of Reproduction"},{"key":"2026021212262259200_bib93","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1542\/peds.2011-0265","article-title":"The risk of necrotizing enterocolitis after indomethacin tocolysis","volume":"128","author":"Sood","year":"2011","journal-title":"Pediatrics"},{"key":"2026021212262259200_bib94","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/cpdd.447","article-title":"Confirmation of the cardiac safety of PGF2alpha receptor antagonist OBE022 in a first-in-human study in healthy subjects, using intensive ECG assessments","volume":"7","author":"Taubel","year":"2018","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"2026021212262259200_bib95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejps.2013.10.007","article-title":"Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women","volume":"52","author":"Terranova","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"2026021212262259200_bib96","doi-asserted-by":"publisher","first-page":"627.e1","DOI":"10.1016\/j.ajog.2009.01.015","article-title":"The effect of Barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Thornton","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2026021212262259200_bib97","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/bcp.13336","article-title":"Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging study","volume":"83","author":"Thornton","year":"2017","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2026021212262259200_bib98","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacology and Therapeutics"},{"key":"2026021212262259200_bib99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02109822","article-title":"Treatment of premature labor with the calcium antagonist nifedipine","volume":"229","author":"Ulmsten","year":"1980","journal-title":"Archives of Gynecology"},{"key":"2026021212262259200_bib100","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00006254-199307000-00026","article-title":"Prostaglandin synthetase inhibitors in pregnancy","volume":"48","author":"Van den Veyver","year":"1993","journal-title":"Obstetrical and Gynecological Survey"},{"key":"2026021212262259200_bib101","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature: New Biology"},{"key":"2026021212262259200_bib102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel","year":"2018","journal-title":"Best Practice and Research. Clinical Obstetrics and Gynaecology"},{"key":"2026021212262259200_bib103","doi-asserted-by":"publisher","first-page":"CD006169","DOI":"10.1002\/14651858.CD006169.pub2","article-title":"Combination of tocolytic agents for inhibiting preterm labour","volume":"7","author":"Vogel","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026021212262259200_bib104","doi-asserted-by":"publisher","first-page":"G390","DOI":"10.1152\/ajpgi.00005.2014","article-title":"Pantoprazole decreases gastroesophageal muscle tone in newborn rats via rho-kinase inhibition","volume":"307","author":"Welsh","year":"2014","journal-title":"American Journal of Physiology: Gastrointestinal and Liver Physiology"},{"key":"2026021212262259200_bib105","doi-asserted-by":"publisher","DOI":"10.1177\/1933719119834079","article-title":"PIPIN: a feasibility trial of pravastatin for the prevention of preterm birth in women trial methods and protocol","volume":"26","author":"Whitaker","year":"2019","journal-title":"Reproductive Sciences"},{"key":"2026021212262259200_bib106","author":"World Health Organisation","year":"2015","journal-title":"WHO Recommendations on Interventions to Improve Preterm Birth Outcomes"},{"key":"2026021212262259200_bib107","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.ctdb.2017.03.001","article-title":"Progesterone receptor signaling in uterine myometrial physiology and preterm birth","volume":"125","author":"Wu","year":"2017","journal-title":"Current Topics in Developmental Biology"},{"key":"2026021212262259200_bib108","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/s0024-3205(0101135-3","article-title":"Inhibitor effect of omeprazole in isolated human myometrial smooth muscle","volume":"69","author":"Yildirim","year":"2001","journal-title":"Life Sciences"},{"key":"2026021212262259200_bib109","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1701-2163(1530565-X","article-title":"The fetal safety of statins: a systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"Journal of Obstetrics and Gynaecology Canada. Journal d'Obst\u00e9trique et Gyn\u00e9cologie du Canada"},{"key":"2026021212262259200_bib110","first-page":"288","article-title":"Clinical observations on the prevention and treatment of premature labor with nifedipine","volume":"33","author":"Zhang","year":"2002","journal-title":"Hua Xi Yi Ke Da Xue Xue Bao"},{"key":"2026021212262259200_bib111","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00006254-197505000-00009","article-title":"Inhibition of human premature labor by indomethacin","volume":"44","author":"Zuckerman","year":"1974","journal-title":"Obstetrics and Gynecology"}],"container-title":["Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/165\/1\/REP-22-0226.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/rep.bioscientifica.com\/downloadpdf\/journals\/rep\/165\/1\/REP-22-0226.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/165\/1\/R9\/64116392\/rep-22-0226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/165\/1\/R9\/64116392\/rep-22-0226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:26:29Z","timestamp":1770917189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/reproduction\/article\/165\/1\/R9\/8217224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/rep-22-0226","relation":{},"ISSN":["1470-1626","1741-7899"],"issn-type":[{"value":"1470-1626","type":"print"},{"value":"1741-7899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,12,2]]}}}